The urinary cotinine levels of infants and the determinants

Gonca Yilmaz1, Candemir Karacan, H Tanju Besler

  • 1Dr. Sami Ulus Children's and Maternity Training and Research Hospital, Ankara, Turkey.

Insights

Infant exposure to tobacco smoke via breast milk significantly elevates cotinine levels. Maternal smoking cessation during breastfeeding is crucial, even when avoiding passive smoke exposure, to protect infant health.

Area of Science:

  • Environmental Health
  • Pediatrics
  • Toxicology

Background:

  • Infant exposure to environmental tobacco smoke (ETS) is a significant health concern.
  • Maternal smoking is a primary source of ETS exposure for infants.
  • Understanding the impact of different exposure routes is vital for infant health interventions.

Purpose of the Study:

  • To investigate the relationship between the route of tobacco smoke exposure and urinary cotinine levels in infants.
  • To quantify the impact of maternal smoking and infant feeding practices on cotinine levels.

Main Methods:

  • Cross-sectional analysis of 254 six-month-old infants.
  • Categorization of infants based on tobacco smoke exposure routes.
  • Measurement of urinary cotinine/creatinine ratios.
  • Linear regression analysis to identify influencing factors.

Main Results:

  • Infants of smoking mothers had significantly higher urinary cotinine levels than those of non-smoking mothers.
  • The highest mean cotinine/creatinine ratio was observed in the breast-milk-exposed group.
  • Maternal smoking increased cotinine levels 541-fold; breastfeeding exposure increased levels 171-fold.
  • Early formula feeding was associated with a 63-fold decrease in cotinine levels.

Conclusions:

  • Tobacco smoke exposure through breast milk may be more detrimental than other exposure routes.
  • Maternal smoking cessation during breastfeeding is strongly recommended, irrespective of passive smoke avoidance.
  • Public health initiatives should emphasize the risks of smoke-contaminated breast milk to infant health.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also be...